Mr. Andrew Casey (Corporate Representative) President & CEO of BIOTECanada

 In his role as President & CEO of BIOTECanada Andrew is responsible for the day-to-day operations of the Association.  In this capacity, he is the primary spokesperson for Canada's biotech industry communicating on the industry's behalf with government, regulators, international bodies, media and the Canadian public. He also ensures BIOTECanada plays a central role in partnership with Government in the development of policy relating to Canada's biotech sector and the member companies of BIOTECanada.

 Prior to joining BIOTECanada, Andrew served from 2004-2012 as Vice President, Public Affairs and International Trade and Vice President, Government Relations and Communications for the Forestry Products Association of Canada. In those roles he held responsibility for the Association’s government relations, communications, media relations, advertising and international trade undertakings. From 1993-2004 he held the position of Assistant Vice-President, Government Relations with the Canadian Life and Health Insurance Association. Between 1989 and 1993 Andrew held political assistant positions with a Member of Parliament and the Minister of State (Finance).

Andrew Casey is a native of Montreal, Quebec. After attending Loyola High School (Montreal) and St. Lawrence CEGEP (Quebec City) he graduated from Carleton University (Ottawa) with a Bachelor of Arts degree in Political Science. 

  

 

Dr. Deborah Marshall (Research Representative) Canada Research Chair, Health Services and Systems Research, University of Calgary

Deborah Marshall holds a Canada Research Chair, Health Services and Systems Research as an Associate Professor at the University of Calgary and Arthur J.E. Child Chair of Rheumatology Outcomes Research in the McCaig Institute of Bone and Joint Health. She is the Director of Health Technology Assessment at the Alberta Bone and Joint Health Institute, a Senior Scientist of the Arthritis Research Center of Canada, and a member of the Institute of Public Health.

She has experience in technology assessment agencies, academia and pharmaceutical and diagnostics industry research settings in Canada, the United States, and Europe. Her research program focuses on health technology assessment – specifically patient preferences, cost-effectiveness analysis, and health systems modeling – to improve the effectiveness and efficiency of health care services.

Dr. Marshall is an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) as the Past President of the Board of Directors and various Task Forces, and a member Board of Directors for Health Technology Assessment International (HTAi).  

Dr. Michel Zummer
(AAC Canadian Rheumatology Association representative)
Head of Rheumatology, CH Maisonneuve-Rosemont, Associate Professor, Université de Montréal

Michel Zummer, M.D., FRCPC received his M.D. from Université Laval, in Ste-Foy, Quebec, and internal medicine and rheumatology training at the Université de Montréal and McGill University.

Dr. Zummer, is Chief of Rheumatology at Maisonneuve-Rosemont Hospital and Associate Professor at Université de Montréal. He is Past-President of the Canadian Rheumatology Association where he now chairs the Access to Care Committee, as well as Past President of the Association des Médecins Rhumatologues de Québec. He is vice-president, North of the PanAmerican League of Associations for Rheumatology and executive member of the Arthritis Alliance of Canada (AAC) where he also co-chairs the Models of Care Committee.

Currently, Dr. Zummer's main focus is improving health care delivery for individuals with rheumatological problems.

 

 

Dr. Deborah Marshall

Dr. Deborah Marshall (Research Representative) Canada Research Chair, Health Services and Systems Research as an Associate Professor

 

Deborah Marshall holds a Canada Research Chair, Health Services and Systems Research as an Associate Professor at the University of Calgary and Arthur J.E. Child Chair of Rheumatology Outcomes Research in the McCaig Institute of Bone and Joint Health. She is the Director of Health Technology Assessment at the Alberta Bone and Joint Health Institute, a Senior Scientist of the Arthritis Research Center of Canada, and a member of the Institute of Public Health.

She has experience in technology assessment agencies, academia and pharmaceutical and diagnostics industry research settings in Canada, the United States, and Europe. Her research program focuses on health technology assessment – specifically patient preferences, cost-effectiveness analysis, and health systems modeling – to improve the effectiveness and efficiency of health care services.

Dr. Marshall is an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) as the Past President of the Board of Directors and various Task Forces, and a member Board of Directors for Health Technology Assessment International (HTAi).  

 

 

Dr. Dianne Mosher

Dr. Dianne Mosher is currently Professor of Medicine and the Chief of the Division of Rheumatology at the University of Calgary. She has practiced Rheumatology for the past twenty years having graduated from Dalhousie Medical School in 1983 where she also completed her Internal Medicine and Rheumatology residency training.

Dr. Mosher is a past president of the Canadian Rheumatology Association and the co -author of "Living Well with Arthritis," Penguin Press, 2002. She was involved in the development of several national initiatives including the "Arthritis Bill of Rights" and was co-chair of the 2005 "Summit on Standards for Arthritis Prevention and Care." In recognition of this work, Dr. Mosher was awarded the Canadian Rheumatology Association Distinguished Rheumatologist Award in 2008.

Dr. Mosher is past co-chair and current president of the Arthritis Alliance of Canada (formerly the Alliance for a Canadian Arthritis Plan), a coalition of arthritis stakeholders. Under her guidance, they released "The Impact of Arthritis in Canada: Today and Over the Next 30 Years" in October of 2011 and the "Joint Action on Arthritis: A Framework to Improve Arthritis Prevention and Care in Canada" in September of 2012.

Her research interests are primarily in clinical epidemiology with a focus on models of care for arthritis and outcome measures for patients with inflammatory arthritis.

In February 2013, she was awarded the Governor General of Canada's Queen Elizabeth Diamond Jubilee Medal to honor her significant work in the area of arthritis care in Canada.